skip to content
Date
28 Apr 2009
Tags
IOC News , Press Release

Beijing 2008: IOC completes further analysis of Beijing samples


The International Olympic Committee (IOC) announced today that it has received the results from the further analysis on the samples collected last summer during the Olympic Games in Beijing. Of 948 samples that were analysed, 7 resulted in an adverse analytical finding (AAF) concerning 6 athletes.
 
Details of the results:
 
Substances
Total number of tests
Number of negative tests
Number of AAFs
CERA
New version of the endurance-enhancing hormone
847
840
7
Insulin
Hormone that can enhance performance by influencing the glycogen metabolism
101
101
0
 
 
“The further analysis of the Beijing samples that we conducted should send a clear message that cheats can never assume that they have avoided detection,” said Arne Ljungqvist, Chairman of the IOC Medical Commission. “The vast majority of athletes do not seek an unfair advantage. We intend to do all we can to ensure that they have a fair environment for competition.”
 
In accordance with the IOC’s usual procedures, the IOC is notifying the athletes of any AAF through their National Olympic Committee (NOC).
 
Any necessary disciplinary procedures, including hearings, will be conducted based upon the IOC’s Anti-Doping Rules applicable to the 2008 Beijing Olympic Games. Pending the decision by the IOC, appropriate steps can be taken by the relevant International Federation, in particular with respect to provisional suspension.
 
Due to the presumption of innocence, the IOC will not comment on any individual case.
 
Background Information
 
As part of its zero-tolerance policy against doping, the IOC is storing samples collected during the Olympic Games for eight years. This allows the IOC to analyse samples retroactively should new fully validated tests to detect new prohibited substances/methods become available.
 
The latest round of testing, which began in January, focused primarily on endurance events in cycling, rowing, swimming and athletics. The testing took advantage of improved technology to seek evidence of the prohibited use of CERA (equivalent to the intake of EPO) and insulin. Most of the work was conducted at the WADA-accredited laboratory in Lausanne, in close collaboration with the accredited labs in Paris and Cologne.
 
More details are provided below.
 
Substances
Tests
Laboratory
CERA
New version of the endurance-enhancing hormone
Blood test recently developed by the WADA-accredited laboratory in Paris and used to retest samples from the Tour de France
Paris/ Lausanne
Insulin
Hormone that can enhance performance by influencing the glycogen metabolism
Urine test recently perfected by the WADA-accredited laboratory in Cologne
Cologne
 
The further analysis effort builds on the approximately 4,770 doping tests that were conducted in Beijing as part of the largest ever testing programme for an Olympic Games. The tests included 3,801 urine and 969 blood tests. Urine tests included 817 EPO tests, and blood tests covered 471 human Growth Hormone (hGH) tests. All the tests covered the 29-day period from 27 July until 24 August 2008. Athletes qualified for the Beijing 2008 Olympic Games were tested by the World Anti-Doping Agency and BOCOG under the authority of the IOC. As a general rule, all top five finishers, plus a further two, were tested.
 
###
 
For further information, please contact the IOC Communications Department, Tel: +41 21 621 60 00, email: pressoffice@olympic.org (Please note that due to previously scheduled technical maintenance work, the IOC's press office will be closed from 18:15 CET this evening and will reopen at 09:00 CET tomorrow, Wednesday 29 April.)
 
back to top